A Study to Evaluate the Efficacy and Safety of CP-101,606 in Subjects With an Acute Stroke

Terminated

Phase 2 Results N/A

Trial Description

The purpose of this study is to determine whether a new research medication is effective and safe for the treatment of acute stroke when given within 6 hours of the onset of stroke.

Conditions

Interventions

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary No or minimal neurological deficit at last visit
Primary Marked neurological improvement at last visit
Secondary Modified Rankin scale at last visit
Secondary Mortality
Secondary Safety assessments

Sponsors